+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Rhinitis"

From
From
From
Middle East and Africa Allergy Treatment Market Outlook, 2030 - Product Thumbnail Image

Middle East and Africa Allergy Treatment Market Outlook, 2030

  • Report
  • August 2025
  • 81 Pages
  • Africa, Middle East
From
From
Asia-Pacific Allergy Treatment Market Outlook, 2030 - Product Thumbnail Image

Asia-Pacific Allergy Treatment Market Outlook, 2030

  • Report
  • August 2025
  • 96 Pages
  • Asia Pacific
From
Europe Allergy Treatment Market Outlook, 2030 - Product Thumbnail Image

Europe Allergy Treatment Market Outlook, 2030

  • Report
  • August 2025
  • 100 Pages
  • Europe
From
Allergy Treatment Market Outlook, 2030 - Product Thumbnail Image

Allergy Treatment Market Outlook, 2030

  • Report
  • August 2025
  • 197 Pages
  • Global
From
Loading Indicator

Rhinitis is a condition of the nose characterized by inflammation of the nasal mucosa, leading to symptoms such as sneezing, nasal congestion, runny nose, and itching. It is a common condition in the field of Allergy and Immunology, and can be caused by allergens, irritants, or infections. Allergic rhinitis is the most common type of rhinitis, and is caused by an allergic reaction to environmental allergens such as pollen, dust mites, and pet dander. Non-allergic rhinitis is caused by irritants such as smoke, strong odors, and weather changes. Treatment for rhinitis typically includes avoidance of triggers, medications, and immunotherapy. Companies in the Rhinitis market include Sanofi, GlaxoSmithKline, Merck, Novartis, and Teva Pharmaceuticals. Show Less Read more